Methuselah's medicine: Pharmaceutical innovation and mortality in the United States, 1960-2000

Social Science and Medicine

Volumn 70, Issue 7, 2010, Pages 961-968

  Schnittker, Jason ^a   Karandinos, George ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Medical innovation; Mortality; Pharmaceuticals; Trends in life expectancy; USA

Indexed keywords

DEMOGRAPHIC TREND; DRUG; HISTORICAL PERSPECTIVE; INNOVATION; LIFE EXPECTANCY; MEDICINE; MORTALITY; TWENTIETH CENTURY;

AGING; ARTICLE; BIRTH; DRUG RESEARCH; HEALTH CARE COST; LIFE EXPECTANCY; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MORTALITY; PREVENTIVE MEDICINE; SEX DIFFERENCE; TREATMENT INDICATION; TREND STUDY; UNITED STATES; DRUG APPROVAL; DRUG DESIGN; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; MASS COMMUNICATION; PHARMACEUTICS; STATISTICS;

UNITED STATES;

DIFFUSION OF INNOVATION; DRUG APPROVAL; DRUG DESIGN; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MORTALITY; SEX FACTORS; TECHNOLOGY, PHARMACEUTICAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77951250532     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2009.11.033     Document Type: Article

References (38)

1. Abelson P.H. Editorial: improvements in health care. Science 1993, 260:11.
2. Beltrán-Sánchez H., Preston S.H., Valdimir C.-R. An integrated approach to cause-of-death analysis: cause-deleted life tables and decompositions of life expectancy. Demographic Research 2008, 19:1323-1350.
3. Braunwald E. Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. New England Journal of Medicine 1997, 337:1360-1369.
4. Carnes B.A., Olshansky S.J. A realist view of aging, mortality, and future longevity. Population and Development Review 2007, 33:367-381.
5. Carter S.B., Gartner S.S., Haines M.R., Olmstead A.L., Sutch R., Wright G. The historical statistics of the United states, millennial edition 2006, Cambridge University, New York.
6. Cleeton D., Goepfrich V.T., Weisbrod B.A. The consumer price index for prescription drugs: dealing with technological change. Health Care Financing Review 1992, 13:45-51.
7. Conrad P. The medicalization of society: On the transformation of human conditions into treatable disorders 2007, Johns Hopkins University, Baltimore, MD.
8. Cutler D. Your money or your life: Strong medicine for America's health care system 2004, Oxford University, New York.
9. Cutler D., Deaton A., Lleras-Muney A. The determinants of mortality. Journal of Economic Perspectives 2006, 97-120.
10. Cutler D.M., Kadiyala S. The return to biomedical research: treatment and behavioral effects. Measuring the gains from medical research: An economic approach 2003, 110-162. University of Chicago, Chicago. K.M. Murphy, R.H. Topel (Eds.).
11. Cutler D., Miller G. The role of public health improvements in health advances: the twentieth-century United States. Demography 2005, 42:1-22.
12. Easterlin R.A. Industrial revolution and mortality revolution: two of a kind?. Journal of Evolutionary Economics 1995, 5:393-408.
13. Ezzati M., Friedman A.B., Kulkarni S.C., Murray C.J.L. The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States. PLoS Medicine 2008, 557-568.
14. Fogel R. The escape from hunger and premature death, 1700 to 2100 2004, Cambridge University, New York.
15. Food and Drug Adminstration Document Management and Reporting Branch Offices of drug evaluation: Statistical report 1989, Division of Management and Budget, Office of Management, Center for Drug Evaluation and Research, Rockville, MD, pp. 152-199.
16. Ford E.S., Ajani U.A., Croft J.B., Critchley J.A., Labarthe D.R., Kottke T.E., et al. Explaining the decrease in U.S. Deaths from coronary disease, 1980-2000. New England Journal of Medicine 2007, 356:23882398.
17. Fuchs V.R., Sox H.C. Physicians' views of the relative importance of thirty medical innovations. Health Affairs 2001, 20:30-42.
18. Goldman D., Smith J.P. Socioeconomic differences in the adoption of new medical technologies. American Economic Review 2005, 95:234-237.
19. Guha S. The importance of social intervention in England's mortality decline: the evidence reviewed. Social History of Medicine 1994, 7:89-113.
20. Heidenreich P., McClellan M. Biomedical research and then some: the causes of technological change in heart attack treatment. Measuring the Gains from medical research: An economic approach 2003, 163-205. University of Chicago Press, Chicago, IL. K.M. Murphy, R.H. Topel (Eds.).
21. Horwitz A.V., Wakefield J.C. The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder 2007, Oxford University Press, New York.
22. Human Mortality Database. Berkeley, USA/Germany: University of California/Max Planck Institute for Demographic Research. Available at: or , accessed on (25/6/07). http://www.humanmortality.de.
23. Kunitz S.J. The health of populations: General theories and particular realities 2007, Oxford University, New York.
24. Lichtenberg F.R. Sources of U.S. longevity increase, 1960 to 1997 2002, Working Paper 8755, NBER, Cambridge, MA.
25. Lichtenberg F., Philipson T. The dual effects of intellectual property regulations: within- and between-patent competition in the U.S. pharmaceuticals industry. Journal of Law and Economics 2002, 45:643-672.
26. Link B.G., Phelan J.C. Social conditions as fundamental causes of disease. Journal of Health and Social Behavior 1995, extra issue:80-94.
27. McKeown T. The role of medicine: Dream, mirage, or nemesis 1976, Nufield Provincial Hospitals Trust, London.
28. Mechanic D. Population health: challenges for science and society. The Milbank Quarterly 2007, 85:533-559.
29. Organization for Economic Cooperation and Development OECD health data 2006 2006, OECD, Paris, France.
30. Potts J.T., Schwartz W.B. The impact of the revolution in biomedical research on life expectancy by 2050. Coping with Methuselah: The impact of Molecular Biology on Medicine and Society 2004, 16-65. Brookings Institution Press, Washington, DC. H.J. Aaron, W.B. Schwartz (Eds.).
31. Preston S.H. The changing relation between mortalitiy and level of economic development. Population Studies 1975, 29:231-248.
32. Preston S.H., Haines M. Fatal years: Child mortality differences in late nineteenth century America 1991, Princeton University, Princeton, NJ.
33. Schwartz W.B. Life without disease: The pursuit of Medical Utopia 2000, University of California, Berkeley, CA.
34. Shekelle P.G., Ortiz E.O., Newberry S.J., Rich M.W., Rhodes S.L., Brook R.H., et al. Identifying potential health care innovations for the future elderly. Health Affairs 2005, W5:67-76.
35. Szreter S. The importance of social intervention in Britain's mortality decline Circa 1850-1914: a reinterpretation of the role of public health. Social History of Medicine 1988, 1:1-37.
36. Thomas L. Notes of a biology-watcher: the technology of medicine. New England Journal of Medicine 1971, 285:1366-1368.
37. Weisbrod B.A. The health care quadrilemma: an essay on technological change, insurance, quality of care, and cost containment. Journal of Economic Literature 1991, 29:523-552.
38. Wilmoth J.K., Andreev K., Jdanov D., Glei D.A. Methods protocol for the human mortality database Available at:. http://www.mortality.org.